Illumina stock eases as Q2 revenue tops $1.16 billion
Published on 08/29/2026 at 10:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Illumina Inc. (US4523271090) stock traded at $228.08 on August 28, 2026, after the company reported second-quarter 2026 revenue of $1.16 billion and earnings per share of $1.31, while guidance for fiscal 2026 EPS moved to $5.30-$5.40.
Quarterly numbers stay firm
The latest quarter beat the $1.23 consensus EPS estimate by $0.08 and came with revenue up 9.4% year over year, according to the same-day market coverage. That mix matters because it shows earnings leverage alongside top-line growth, not just a one-off beat.
MarketBeat's stock chart page showed a latest close of $224.99 and a market cap of $33.97 billion, while another same-day market snapshot put the opening price at $227.69 and the market cap at $34.38 billion. The gap between those two levels leaves the shares trading in the upper-$220s after the Q2 release and the updated outlook.
Guidance now carries weight
Fiscal 2026 EPS guidance at $5.30-$5.40 gives investors a tighter frame for the rest of the year, and the same coverage put current-year EPS expectations at $5.36. Against that backdrop, the quarter's $1.16 billion in revenue and $1.31 in EPS become the numbers that matter most for valuation.
Recent coverage also tied the stock's late-August tone to insider sale disclosures and a new $1.0 billion revolving credit facility, while the operating side still points to a business with 18.36% net margin and 29.84% return on equity in Q2 2026.
Instrument demand still matters
Illumina's sequencing systems and consumables remain the core commercial engine, and the latest quarter again showed why that mix matters for margins and cash generation. A $1.16 billion quarter against $1.13 billion of expected revenue is a useful signal for investors tracking whether growth is broad enough to support the raised outlook.
Shares and valuation
Illumina stock last traded at $228.08 on August 28, 2026, versus a latest close of $224.99 on the chart page and a 52-week range cited by market data of $88.00 to $231.81. For now, the question is whether the stock can hold near the upper end of that band while the market absorbs the updated full-year guide.
Company
Company: Illumina Inc.
ISIN: US4523271090
Ticker: ILMN
Exchange: Nasdaq
Price (as of August 28, 2026, 11:22 a.m. ET): $228.08 USD
Market cap: $34.38 billion (as of August 28, 2026)
Sector / Industry: Health Care / Life Sciences Tools & Services
Index membership: Nasdaq-100
More on Illumina stock
Illumina's sequencing platforms underpin its revenue base, with consumables and instruments driving most customer activity across research, clinical, and applied markets.
More on Illumina stock
Illumina stock traded at $228.08 on August 28, 2026, and the latest reported quarter showed $1.16 billion in revenue and $1.31 in EPS.
